InvestorsHub Logo
Followers 23
Posts 1331
Boards Moderated 1
Alias Born 09/25/2018

Re: flipper44 post# 227248

Monday, 05/13/2019 11:09:10 PM

Monday, May 13, 2019 11:09:10 PM

Post# of 704118
First version you said started in November, 2019.

flipper44 has replied to a post you made on NorthWest Biotherapeutics Inc. on Investors Hub:
They started the rereview of progression events back in November 2019. The crossover has been known for the length of the trial. The statement is simply attempting to explain why they've been taking so long. IMO, they are just trying to mature the data further, and they've always had their own internal timeline. Comes as no surprise to them, imo.
To VIEW or REPLY TO this message, click the link below:
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News